RESUMEN
Local data regarding Manchester repair are not available in the current literature. We report a retrospective case series of 7 women who presented with uterine prolapse, and underwent Manchester repair from January 1997 to May 2008 at King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia. All of these women were multiparous (para 31) and wanted to avoid hysterectomy, and become pregnant. The duration of the procedure was 119 16 minutes. No operative complications were observed. The mean duration of follow up was 52 years. All of the women were satisfied with the procedure. Two (28.6%) patients subsequently became pregnant and had a successful vaginal delivery. Manchester repair is a valid alternative to hysterectomy for women with a second degree uterine prolapse who want to preserve their fertility.
Asunto(s)
Ligamento Ancho/cirugía , Cuello del Útero/cirugía , Procedimientos Quirúrgicos Ginecológicos/métodos , Prolapso Uterino/cirugía , Adulto , Femenino , Estudios de Seguimiento , Procedimientos Quirúrgicos Ginecológicos/efectos adversos , Hospitales Universitarios , Humanos , Histerectomía , Satisfacción del Paciente , Recurrencia , Estudios Retrospectivos , Medición de Riesgo , Muestreo , Índice de Severidad de la Enfermedad , Técnicas de Sutura , Resultado del Tratamiento , Prolapso Uterino/diagnósticoRESUMEN
BACKGROUND: There is limited data on chemotherapy for advanced ovarian cancer during pregnancy. Most women received cisplatin-based chemotherapy. There are no published reports on the use of docetaxel for ovarian cancer in pregnancy. CASE: A 32-year-old pregnant lady underwent laparatomy at 18-week gestation for ruptured ovarian cyst. The pregnancy was the result of in vitro fertilization with intracytoplasmic sperm injection. Left salpingo-oophorectomy and omental biopsy were done. A diagnosis of stage IIIC, poorly differentiated papillary serous adenocarcinoma of the ovary was made. She was given four cycles of cisplatinum and docetaxel followed by cesarean hysterectomy, right salpingo-oophorectomy, and cytoreductive surgery. The mother is well and has completed six cycle of chemotherapy. CONCLUSION: This is the first report on the use of docetaxel during pregnancy for ovarian cancer.